Amplia Therapeutics Ltd.ASX: ATX

First Human Dose in Phase 1 Clinical Trial of AMP945

Oct 8, 2020 at 5:19 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment